XVA143
XVA143, an α/β I-like allosteric antagonist, inhibits LFA-1 dependent firm adhesion, while at the same time it enhances adhesion in shear flow and rolling both in vitro and in vivo[1].
Product Specifications
CAS Number
264275-77-6
UNSPSC
12352005
Target
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/xva143.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)[C@H](CNC(C1=CC(O)=CC(O)=C1)=O)NC(C2=C(Cl)C=C(C(NCC3=CC=CC(O)=C3)=O)C=C2Cl)=O
Molecular Formula
C25H21Cl2N3O8
Molecular Weight
562.36
References & Citations
[1]Azucena Salas, et al. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity. 2004 Apr;20 (4) :393-406.|[2]Mélanie R Tardif, et al. LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20. Antimicrob Agents Chemother. 2009 Nov;53 (11) :4656-66.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMAB-04549-01 50 μL
Anti-Complement component C9b Polyclonal Antibody 2
Sign In for Pricing
View Details TMAB-04549-02 100 µL
Anti-Complement component C9b Polyclonal Antibody 2
Sign In for Pricing
View Details TMAB-04549-03 200 µL
Anti-Complement component C9b Polyclonal Antibody 2
Sign In for Pricing
View Details ![Rabbit Polyclonal AF9 Antibody [DyLight 405]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)